APLLTD — Alembic Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹221.89bn
- IN₹225.61bn
- IN₹62.29bn
- 98
- 17
- 84
- 80
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9,998 | 13,681 | 6,201 | 3,546 | 6,318 |
Depreciation | |||||
Non-Cash Items | 1,210 | -823 | 1,363 | 2,122 | 142 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -8,290 | -58.7 | -4,908 | -1,183 | -1,155 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4,491 | 14,634 | 5,524 | 7,240 | 8,032 |
Capital Expenditures | -7,349 | -6,595 | -4,256 | -4,434 | -3,275 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 32.7 | -1,793 | 537 | -41.8 | 68.6 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -7,316 | -8,388 | -3,720 | -4,476 | -3,206 |
Financing Cash Flow Items | 3,203 | -9,335 | -520 | -482 | -494 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1,549 | -5,974 | -2,174 | -2,620 | -4,379 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,272 | 262 | -370 | 144 | 447 |